<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        61-325-02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GASTROZOLE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OMEPRAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gastro-resistant capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        41.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gastrozole Capsules contain the active substance omeprazole. It belongs to a group of medicines called &lsquo;proton pump inhibitors&rsquo;. They work by reducing the amount of acid that your stomach produces. Gastrozole Capsules are used to treat the following conditions:</p><p><u>In adults: </u></p><ul><li>&nbsp; &lsquo;Gastro-oesophageal reflux disease&rsquo; (GERD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn.</li><li>&nbsp;Ulcers in the upper part of the intestine (duodenal ulcer) or stomach (gastric ulcer).</li><li>&nbsp;Ulcers which are infected with bacteria called &lsquo;Helicobacter pylori&rsquo;. If you have this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.</li><li>Ulcers caused by medicines called NSAIDs (Non-Steroidal Anti-inflammatory Drugs). Gastrozole Capsules can also be used to stop ulcers from forming if you are taking NSAIDs.</li><li>&nbsp; Too much acid in the stomach caused by a growth in the pancreas (Zollinger-Ellison syndrome).</li><li><strong><u>In children: </u></strong></li></ul><p><strong>Children over 1 year of age and &ge; 10 kg </strong></p><ul><li>&nbsp; &lsquo;Gastro-oesophageal reflux disease&rsquo; (GERD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn.</li><li>In children, the symptoms of the condition can include the return of stomach contents into the mouth (regurgitation), being sick (vomiting) and poor weight gain.</li></ul><p><strong>Children and adolescents over 4 years of age </strong></p><ul><li>&nbsp; Ulcers which are infected with bacteria called &lsquo;Helicobacter pylori&rsquo;. If your child has this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Subacute cutaneous lupus erythematosus (SCLE)</strong></p><p>Proton pump inhibitors are associated with very frequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping this medication. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p><strong>Do not take Gastrozole Capsules: </strong></p><ul><li>&nbsp; If you are allergic (hypersensitive) to omeprazole or any of the other ingredients of Gastrozole Capsules (listed in section 6)</li><li>&nbsp; If you are allergic to medicines containing other proton pump inhibitors (e.g. pantoprazole, lansoprazole, rebeprazole, esomeprazole)</li><li>&nbsp;If you are taking a medicine containing nelfinavir (used for HIV infection).</li></ul><p>If you are not sure, talk to your doctor or pharmacist before taking Gastrozole Capsules.</p><p><strong>Take special care with Gastrozole Capsules </strong></p><p>Omeprazole may hide the symptoms of other diseases. Therefore, if any of the following happen to you before you start taking Gastrozole Capsules or while you are taking them, talk to your doctor straightaway:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You lose a lot of weight for no reason and have problems swallowing.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You get stomach pain or indigestion.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You begin to vomit food or vomit blood.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You pass black stools (blood-stained faeces).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You experience severe or persistent diarrhoea, as omeprazole has been associated with a small increase in infectious diarrhoea.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have severe liver problems.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had a skin reaction after treatment with a medicine similar to Gastrozole that reduces stomach acid.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are due to have a specific blood test (Chromogranin A).</p><p>&nbsp;</p><p>If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Gastrozole. Remember to also mention any other ill-effects like pain in your joints.</p><p>&nbsp;</p><p>Taking a proton pump inhibitor like Omeprazole, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).</p><p>&nbsp;</p><p>If you take Gastrozole Capsules on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor</p><p>&nbsp;</p><p><strong>Taking Other medicines </strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is because Gastrozole Capsules can affect the way some medicines work and some medicines can have an effect on Gastrozole Capsules.</p><p>&nbsp;</p><p>Do not take Gastrozole Capsules if you are taking a medicine containing nelfinavir (used to treat HIV infection).</p><p>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking any of the following medicines:</p><ul><li>&nbsp; Ketoconazole, posoconazole , itraconazole or voriconazole (used to treat infections caused by a fungus)</li><li>&nbsp; Digoxin (used to treat heart problems)</li><li>&nbsp; Diazepam (used to treat anxiety, relax muscles or in epilepsy)</li><li>&nbsp; Phenytoin (used in epilepsy). If you are taking phenytoin, your doctor will need to monitor you when you start or stop taking Gastrozole Capsules</li><li>&nbsp; Medicines used to thin the blood, such as warfarin or other vitamin K blockers. Your doctor may need to monitor you when you start or stop taking Gastrozole Capsules</li><li>&nbsp; Rifampicin (used to treat tuberculosis)</li><li>&nbsp; Atazanavir (used to treat HIV infection)</li><li>&nbsp; Tacrolimus (in cases of organ transplantation)</li><li>&nbsp; St John&rsquo;s wort (hypericum perforatum) (used to treat mild depression)</li><li>&nbsp; Cilostazol (used to treat intermittent claudication)</li><li>&nbsp; Saquinavir (used to treat HIV infection)</li><li>&nbsp; Clopidogrel (used to prevent blood clots (thrombi))</li><li>&nbsp; Erlotinib (used to treat cancer)</li><li>&nbsp; Methotrexate (a chemotherapy medicine used in high doses to treat cancer) &ndash; if you are taking a high dose of methotrexate, your doctor may temporarily stop your omeprazole treatment.</li></ul><p>If your doctor has prescribed the antibiotics amoxicillin and clarithromycin as well as Gastrozole Capsules to treat ulcers caused by Helicobacter pylori infection, it is very important that you tell your doctor about any other medicines you are taking.</p><p><strong>&nbsp;</strong></p><p><strong>Taking Gastrozole Capsules with food and drink </strong></p><p>You can take your capsules with food or on an empty stomach. They should NOT be chewed or crushed. They should be swallowed whole with a glass of water.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>Omeprazole is excreted in breast milk but is not likely to influence the child when therapeutic doses are used. Your doctor will decide whether you can take Gastrozole if you are breastfeeding.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>Gastrozole Capsules is not likely to affect your ability to drive or use any tools or machines. Side effects such as dizziness and visual disturbances may occur (see section 4). If affected, you should not drive or operate machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Gastrozole Capsules exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Your doctor will tell you how many capsules to take, and how long to take them for. This will depend on your condition and how old you are. The usual doses are given below.</p><p><u>Adults: </u></p><p>To treat symptoms of GERD such as <strong>heartburn and acid regurgitation</strong>:</p><ul><li>&nbsp;If your doctor has found that your food pipe (gullet) has been slightly damaged, the usual dose is 20 mg once a day for 4 - 8 weeks. Your doctor may tell you to take a dose of 40 mg for a further 8 weeks if your gullet has not yet healed.</li><li>&nbsp; The usual dose once the gullet has healed is 10 mg once a day.</li><li>&nbsp; If your gullet has not been damaged, the usual dose is 10 mg once a day.<strong>&nbsp;</strong></li></ul><p>To<strong> treat ulcers in the upper part of the intestine</strong> (duodenal ulcer):</p><ul><li>&nbsp; The usual dose is 20 mg once a day for 2 weeks. Your doctor may tell you to take the same dose for a further 2 weeks if your ulcer has not yet healed.</li><li>&nbsp; If the ulcer does not fully heal, the dose can be increased to 40 mg once a day for 4 weeks.<strong>&nbsp;</strong></li></ul><p>To<strong> treat ulcers in the stomach </strong>(gastric ulcer):</p><ul><li>&nbsp; The usual dose is 20 mg once a day for 4 weeks. Your doctor may tell you to take the same dose for a further 4 weeks if your ulcer has not yet healed.</li><li>If the ulcer does not fully heal, the dose can be increased to 40 mg once a day for 8 weeks.</li></ul><p>To<strong> prevent the duodenal and stomach ulcers</strong> from coming back:</p><ul><li>&nbsp;The usual dose is 10 mg or 20 mg once a day. Your doctor may increase the dose to 40 mg once a day.</li></ul><p>&nbsp;</p><p>To<strong> treat duodenal and stomach</strong> <strong>ulcers caused by NSAIDs</strong> (NonSteroidal Anti-Inflammatory Drugs):</p><ul><li>&nbsp;The usual dose is 20 mg once a day for 4&ndash;8 weeks.</li></ul><p><strong>&nbsp;</strong></p><p>To<strong> prevent duodenal and stomach ulcers</strong> <strong>caused by NSAIDs</strong>:</p><ul><li>&nbsp;The usual dose is 20 mg once a day.</li></ul><p>&nbsp;</p><p>To<strong> treat</strong> <strong>ulcers caused by Helicobacter pylori</strong> infection and to stop them coming back:</p><ul><li>&nbsp;The usual dose is 20 mg omeprazole twice a day for one week.</li><li>&nbsp;Your doctor will also tell you to take two antibiotics among amoxicillin, clarithromycin and metronidazole.</li></ul><p>To treat too much acid in the stomach caused by a <strong>growth in the pancreas (Zollinger-Ellison syndrome)</strong>:</p><ul><li>&nbsp; The usual dose is 60 mg daily.</li><li>&nbsp; Your doctor will adjust the dose depending on your needs and will also decide how long you need to take the medicine for.</li></ul><p><u>Use in Children</u></p><p>To treat symptoms of GERD such as <strong>heartburn and acid regurgitation</strong>:</p><ul><li>Children over 1 year of age and with a body weight of more than 10 kg may take omeprazole. The dose for children is based on the child&rsquo;s weight and the doctor will decide the correct dose.</li></ul><p>To treat <strong>ulcers caused by Helicobacter pylori</strong> infection and to stop them coming back:</p><ul><li>&nbsp; Children aged over 4 years may take omeprazole. The dose for children is based on the child&rsquo;s weight and the doctor will decide the correct dose.</li><li>&nbsp;Your doctor will also prescribe two antibiotics called amoxicillin and clarithromycin for your child.</li></ul><p><strong>Taking this medicine </strong></p><ul><li>&nbsp; It is recommended that you take your capsules in the morning.</li><li>&nbsp; You can take your capsules with food or on an empty stomach.</li><li>&nbsp; Swallow your capsules whole with half a glass of water. Do not chew or crush the capsules. This is because the capsules contain coated pellets which stop the medicine from being broken down by the acid in your stomach. It is important not to damage the pellets.</li></ul><p><strong>What to do if you or your child have trouble swallowing the</strong> <strong>capsules</strong></p><ul><li>&nbsp;If you or your child has trouble swallowing the capsules:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Open the capsules and swallow the contents directly with half a glass of water or put the contents into a glass of still (non-fizzy) water, any acidic fruit juice (e.g. apple, orange or pineapple) or apple sauce.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always stir the mixture just before drinking it (the mixture will not be clear). Then drink the mixture straight away or within 30 minutes.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To make sure that you have drunk all of the medicine, rinse the glass very well with half a glass of water and drink it. The solid pieces contain the medicine - do not chew or crush them.</p><p><strong>&nbsp;</strong></p><p><strong>If you take more Gastrozole Capsules than you should </strong></p><p>If you take more Gastrozole Capsules than prescribed by your doctor, talk to your doctor or pharmacist straight away.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take Gastrozole Capsules</strong></p><p>If you forget to take a dose, take it as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you have any further questions on the use of this product, ask your doctor, health care provider or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Gastrozole Capsules can cause side effects, although not everybody gets them.</p><p><strong>If you notice any of the following rare but serious side effects, stop taking Gastrozole Capsules and contact a doctor immediately </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden wheezing, swelling of your lips, tongue and throat or body, rash, fainting or difficulties in swallowing (severe allergic reaction).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reddening of the skin with blisters or peeling. There may be severe blisters and bleeding in the lips, eyes, mouth, nose and genitals &ndash; this could be &lsquo;Stevens-Johnson Syndrome&rsquo; or &lsquo;toxic epidermal necrolysis&rsquo;.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellow skin, dark urine and tiredness which can be symptoms of liver problems.</p><p>&nbsp;</p><p>Other side effects include:</p><p><strong>Common side effects</strong> <strong>(may affect up to 1 in 10 people)</strong></p><ul><li>Headache.</li><li>&nbsp;Effects on your stomach or gut: diarrhoea, stomach pain, constipation, wind (flatulence).</li><li>&nbsp; Feeling sick (nausea) or being sick (vomiting).</li><li><strong>&nbsp;</strong></li></ul><p><strong>Uncommon side effects</strong> <strong>(may affect up to 1 in 100 people)</strong></p><ul><li>&nbsp; Swelling of the feet and ankles.</li><li>&nbsp; Disturbed sleep (insomnia).</li><li>&nbsp; Dizziness, tingling feelings such as &ldquo;pins and needles&rdquo;, feeling sleepy.</li><li>&nbsp; Spinning feeling (vertigo).</li><li>&nbsp; Changes in blood tests that check how the liver is working.</li><li>&nbsp; Skin rash, lumpy rash (hives) and itchy skin.</li><li>&nbsp; Generally feeling unwell and lacking energy.<strong>&nbsp;</strong></li></ul><p><strong>Rare side effects (may affect up to 1 in 1,000 people)</strong></p><ul><li>&nbsp; Blood problems such as a reduced number of white cells or platelets. This can cause weakness, bruising or make infections more likely.</li><li>&nbsp; Allergic reactions, sometimes very severe, including swelling of the lips, tongue and throat, fever, wheezing.</li><li>&nbsp; Low levels of sodium in the blood. This may cause weakness, being sick (vomiting) and cramps.</li><li>&nbsp; Feeling agitated, confused or depressed.</li><li>&nbsp; Taste changes.</li><li>&nbsp; Eyesight problems such as blurred vision.</li><li>&nbsp; Suddenly feeling wheezy or short of breath (bronchospasm).</li><li>&nbsp; Dry mouth.</li><li>&nbsp; An inflammation of the inside of the mouth.</li><li>&nbsp; An infection called &ldquo;thrush&rdquo; which can affect the gut and is caused by a fungus.</li><li>&nbsp; Liver problems, including jaundice which can cause yellow skin, dark urine, and tiredness.</li><li>&nbsp; Hair loss (alopecia).</li><li>&nbsp; Skin rash on exposure to sunshine.</li><li>&nbsp; Joint pains (arthralgia) or muscle pains (myalgia).</li><li>&nbsp; Severe kidney problems (interstitial nephritis).</li><li>&nbsp; Increased sweating.<strong>&nbsp;</strong></li></ul><p><strong>Very rare side effects</strong> <strong>(may affect up to 1 in 10,000 people)</strong></p><ul><li>&nbsp; Changes in blood count including agranulocytosis (lack of white blood cells).</li><li>&nbsp;Aggression.</li><li>&nbsp; Seeing, feeling or hearing things that are not there (hallucinations).</li><li>&nbsp; Severe liver problems leading to liver failure and inflammation of the brain.</li><li>Sudden onset of a severe rash or blistering or peeling skin. This may be associated with a high fever and joint pains (Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).</li><li>&nbsp; Muscle weakness.</li><li>&nbsp; Enlarged breasts in men.</li><li><strong>Not known (frequency cannot be estimated from available data) </strong></li><li>&nbsp; Inflammation in the gut (leading to diarrhoea).</li><li>&nbsp; If you are on Omeprazole for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.</li><li>&nbsp; &nbsp;Rash, possibly with pain in the joints</li></ul><p>&nbsp;</p><p>Gastrozole Capsules may in very rare cases affect the white blood cells leading to immune deficiency. If you have an infection with symptoms such as fever with a severely reduced general condition or fever with symptoms of a local infection such as pain in the neck, throat or mouth or difficulties in urinating, you must consult your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important for you to give information about your medicine at this time.</p><p>&nbsp;</p><p><strong>If any side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. </strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30 &deg;C.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store it in the original package to protect from light and moisture.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Gastrozole Capsules after the expiry date which is stated on the pack after EXP. The expiry date refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask you pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Gastrozole Capsules contain </strong></p><ul><li>&nbsp; The active substance: Each Gastrozole Capsule contains omeprazole pellets 8.5% (20 mg).</li><li>&nbsp; Capsule shell: RC 14 (size 2).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Capsules having grey opaque body and green opaque head with printing RP14 in white ink on head containing white to off white spherical enteric coated pellets.

Pack contains 14 capsules in a white jar .

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorisation holder:</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                8/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">جاستروزول كبسولات تحتوي على المادة الفعالة أوميبرازول. وهو ينتمي إلى مجموعة من الأدوية تسمى &rsquo;مثبطات مضخة البروتون&rsquo;. وهي تعمل عن طريق تقليل كمية الحمض التي تنتجها معدتك. وتستخدم كبسولات جاستروزول لعلاج الحالات التالية:</p><p dir="RTL"><u>في البالغين:</u></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rsquo;مرض الارتجاع المعدي المريئي&rsquo; (GERD). وهو رجوع الحمض من المعدة إلى المريء (الأنبوب الذي يربط الحلق بالمعدة) مما يسبب ألم والتهاب وحرقة.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;قرح في الجزء العلوي من الأمعاء (قرحة الاثنى عشر) أو المعدة (قرحة المعدة).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;قرح مصابة ببكتيريا تسمى &quot;هيليكوباكتر بيلوري&quot;. إذا كان لديك هذه الحالة، قد يصف لك الطبيب أيضا المضادات الحيوية لعلاج العدوى، واعطاء الفرصة للقرحة للإلتئام.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;القرح التي تسببها أدوية تسمى مضادات الالتهاب غير الستيرويدية. ويمكن أيضا أن تستخدم كبسولات جاستروزول لوقف القرح من التكون إذا كنت تتناول مضادات الالتهاب غير الستيرويدية.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; كثرة الحمض في المعدة الناجمة عن النمو في البنكرياس (متلازمة زولينجر إليسون).</li><li><u>في الأطفال:</u></li></ul><p dir="RTL"><strong>الأطفال أكثر من 1 سنة من العمر، و&ge; 10 كجم</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&quot;مرض الارتجاع المعدي المريئي&quot; (GERD). وهو رجوع الحمض من المعدة إلى المريء (الأنبوب الذي يربط الحلق بالمعدة) مما يسبب ألم والتهاب وحرقة.</li><li>في الأطفال، الأعراض في هذه الحالة قد تتضمن عودة محتويات المعدة إلى الفم (ارتجاع)، والشعور المرضي (القيء) وقلة زيادة الوزن.</li></ul><p dir="RTL"><strong>الأطفال والمراهقين أكثر من 4 سنوات من العمر</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;القرح المصابة ببكتيريا تسمى &quot;هيليكوباكتر بيلوري&quot;. إذا كان طفلك يعاني من هذه الحالة، قد يصف الطبيب أيضا المضادات الحيوية لعلاج العدوى، واعطاء الفرصة للقرحة للإلتئام.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الذئبة الحمامية الجلدية شبة الحادة (</strong><strong>SCLE</strong><strong>)</strong></p><p dir="RTL">ترتبط مثبطات مضخة البروتون مع حالات متكررة جدا من SCLE. في حالة حدوث جروح، وخاصة في المناطق المعرضة للشمس من الجلد، وإذا رافقه ألم مفصلي، ينبغي على المريض طلب المساعدة الطبية فورا وعلى مقدم الرعاية الصحية المهنية أن يبحث وضع ايقاف هذا الدواء. حدوث SCLE مع علاجات سابقة بمثبطات مضخة البروتون قد تزيد من خطر الإصابة بــ SCLE مع غيرها من مثبطات مضخة البروتون.</p><p dir="RTL"><strong>لا تتناول كبسولات جاستروزول:</strong></p><ul dir="rtl"><li><strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>إذا كان لديك حساسية (فرط الحساسية) لأوميبرازول أو أي من المكونات الأخرى من كبسولات جاستروزول (المدرجة في القسم 6)</li><li><strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>إذا كان لديك حساسية من الأدوية التي تحتوي على غيرها من مثبطات مضخة البروتون (على سبيل المثال بانتوبرازول، لانزوبرازول، ربيبرازول، إيسوميبرازول)</li><li><strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>إذا كنت تتناول &nbsp;دواء يحتوي على نلفينافير (الذي يستخدم لعدوى فيروس نقص المناعة البشرية).</li></ul><p dir="RTL">إذا لم تكن متأكدا، تحدث مع طبيبك أو الصيدلي قبل تناول كبسولات جاستروزول.</p><p dir="RTL"><strong>عناية خاصة مع كبسولات جاستروزول </strong></p><p dir="RTL">أوميبرازول قد يخفي أعراض أمراض أخرى. ولذلك، إذا أي مما يلي حدث لك قبل البدء بتناول كبسولات جاستروزول أو أثناء تناولها، تحدث الى الطبيب الخاص بك فورا:</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تفقد الكثير من الوزن دون سبب وتعاني من مشاكل في البلع.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>يمكن أن يحدث لك آلام في المعدة أو عسر الهضم.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>أن تبدأ في تقيؤ الطعام أو تقيؤ دم.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إخراج براز أسود (براز ملطخة بالدماء).</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>عانيت من الإسهال الشديد أو المستمر، حيث أن أوميبرازول مرتبط مع زيادة طفيفة في الإسهال الناتج عن العدوى.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>لديك مشاكل خطيرة &nbsp;في الكبد.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كنت قد عانيت من تفاعل الجلد بعد العلاج باستخدام دواء مشابه لكبسولات جاستروزول الذي يقلل من حامض المعدة.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>اذا كان من المقرر إجراء اختبار دم محدد (Chromogranin A).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا حصلت على طفح جلدي على بشرتك ، خاصةً في المناطق المعرضة للشمس ، أخبر طبيبك بأسرع ما يمكن ، لأنك قد تحتاج إلى إيقاف علاجك بكبسولات جاستروزول . تذكر أيضًا ذكر أي آثار جانبية أخرى مثل ألم في مفاصلك .</p><p dir="RTL">&nbsp;</p><p dir="RTL">تناول مثبطات مضخة البروتون مثل أوميبرازول، وخاصة لفترة أكثر من سنة واحدة، قد يزيد قليلا من خطر الإصابة بكسور في الفخذ أوالمعصم أو العمود الفقري. أخبر طبيبك إذا كان لديك مرض هشاشة العظام أو إذا كنت تستخدم الكورتيكوستيرويدات (التي يمكن أن تزيد من خطر هشاشة العظام).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تتناول كبسولات جاستروزول لفترة طويلة الأجل (أطول من 1 سنة) من المحتمل أن يبقيك طبيبك تحت المراقبة الاعتيادية. يجب إبلاغ طبيبك عن أي أعراض أوظروف جديدة أواستثنائية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول الأدوية الأخرى </strong></p><p dir="RTL">يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية. وذلك لأن كبسولات جاستروزول يمكن أن تؤثر على الطريقة التي تعمل بها بعض الأدوية ويمكن لبعض الأدوية أن يكون لها تأثير على كبسولات جاستروزول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتناول كبسولات جاستروزول إذا كنت تتناول دواء يحتوي على نلفينافير (الذي تستخدم لعلاج عدوى فيروس نقص المناعة البشرية)</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أي من الأدوية التالية:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;كيتوكونازول، بوسوكونازول ، إتراكونازول أو فوريكونازول (التي تستخدم لعلاج العدوى الفطرية)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الديجوكسين (التي تستخدم لعلاج مشاكل القلب)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ديازيبام (التي تستخدم لعلاج القلق، و مرخي للعضلات أو في الصرع)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الفينيتوين (المستخدم في الصرع). إذا كنت تستخدم الفينيتوين، طبيبك سوف يحتاج إلى مراقبتك عند بدء أو التوقف عن تناول كبسولات جاستروزول .</li><li>&nbsp; &nbsp; &nbsp; &nbsp; الأدوية المستعملة لسيولة الدم، مثل الوارفارين أو غيرها من حاصرات فيتامين K. طبيبك قد يحتاج إلى مراقبتك عند البدء أو التوقف عن تناول كبسولات جاستروزول</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ريفامبيسين (التي تستخدم لعلاج السل)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اتازنفير (التي تستخدم لعلاج عدوى فيروس نقص المناعة البشرية)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;التاكروليموس (في حالات زرع الأعضاء)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;نبتة سانت جون (هيبيريكم بيرفوراتوم) (التي تستخدم لعلاج الاكتئاب الخفيف)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;سيلوستازول (التي تستخدم لعلاج العرج المتقطع)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ساكوينافير (التي تستخدم لعلاج عدوى فيروس نقص المناعة البشرية)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;كلوبيدوجريل (التي تستخدم لمنع تجلط الدم (الجلطة))</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إرلوتينيب (التي تستخدم لعلاج السرطان)</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الميثوتريكسيت (دواء علاج كيميائي يستخدم بجرعات عالية لعلاج السرطان) &ndash; إذا كنت تتناول جرعة عالية من الميثوتريكسيت، طبيبك قد يوقف علاج أوميبرازول مؤقتا.</li></ul><p dir="RTL">إذا كان طبيبك قد وصف لك المضادات الحيوية أموكسيسيلين وكلاريثروميسين وكذلك كبسولات جاستروزول لعلاج القرحة التي تسببها عدوى هيليكوباكتر بيلوري، من المهم جدا أن تخبر طبيبك عن أي أدوية أخرى تتناولها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول كبسولات &nbsp;جاستروزول مع الطعام والشراب</strong></p><p dir="RTL">يمكنك أن تتناول الكبسولات الخاصة بك مع الطعام أو على معدة فارغة . لا ينبغي مضغها أو سحقها. يجب ابتلاعها كاملة مع كوب من الماء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنتي حاملًا أو ترضعين طفلك رضاعة طبيعية ، تظنين أنكي قد تكونين حاملاً أو تخططين لإنجاب طفل ، اسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول هذا الدواء.</p><p dir="RTL">يفرز اوميبرازول في حليب الثدي ولكن ليس من المرجح أن يؤثر على الطفل عند استخدام الجرعات العلاجية. سيقرر طبيبك ما إذا كنتي تستطيعين تناول كبسولات جاستروزول &nbsp;إذا كنتي ترضعين طفلك رضاعة طبيعية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">ليس من المرجح أن تؤثر كبسولات جاستروزول على قدرتك على القيادة أو استخدام أي أدوات أو آلات. قد تحدث آثار جانبية مثل الدوخة واضطرابات بصرية (انظر القسم 4). إذا تأثرت، يجب ألا تقود السيارة أو تشغل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائما جاستروزول كبسولات تماما كما أخبرك طبيبك. يجب عليك التحقق مع طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL">طبيبك سوف يخبرك بكم الكبسولات التي يجب أن تتناولها، والى متى. وهذا يعتمد على حالتك وعمرك. وفيما يلي الجرعات المعتادة.</p><p dir="RTL"><u>الكبار:</u></p><p dir="RTL">لعلاج أعراض مرض الارتجاع المعدي المريئي (GERD) مثل <strong>الحرقة وارتجاع الحمض</strong>:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا وجد طبيبك أن المريء لديك قد تضرر قليلا فإن الجرعة المعتادة هي 20 ملجم مرة واحدة يوميا لمدة 4-8 أسابيع. طبيبك قد يقول لك أن تتناول جرعة 40 ملجم لمدة 8 أسابيع أخرى إذا لم يتعاف المريء لديك.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة بعد التئام المريء هي 10 ملجم مرة واحدة يوميا.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا لم يكن المريء قد تلف لديك، فالجرعة المعتادة هي 10 ملجم مرة واحدة يوميا.</li><li><strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>لعلاج قرح الجزء العلوي من الأمعاء (قرحة الاثنى عشر):</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 20 ملجم مرة واحدة يوميا لمدة أسبوعين. طبيبك قد يقول لك أن تتناول نفس الجرعة لأسبوعين أخرىين إذا لم تلتئم بعد القرحة لديك.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا لم تلتئم القرحة تماما&nbsp;يمكن زيادة الجرعة إلى 40 ملجم مرة واحدة يوميا لمدة 4 أسابيع.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لعلاج قرح في المعدة </strong>(قرحة المعدة):</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 20 ملجم مرة واحدة يوميا لمدة 4 أسابيع. طبيبك قد يقول لك أن تتناول نفس الجرعة لمدة 4 أسابيع أخرى إذا لم تلتئم بعد القرحة لديك.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا لم تلتئم القرحة تماما، يمكن زيادة الجرعة إلى 40 ملجم مرة واحدة يوميا لمدة 8 أسابيع.</li></ul><p dir="RTL"><strong>لمنع قرح المعدة والاثنى عشر </strong>من الحدوث مرة أخرى:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 10 ملجم أو 20 ملجم مرة واحدة يوميا. طبيبك قد يزيد الجرعة إلى 40 ملجم مرة واحدة يوميا.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج قرح المعدة والاثنى</strong> <strong>عشر التي تسببها مضادات الالتهاب غير الستيرويدية</strong> (الأدوية المسكنة المضادة للالتهابات):</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 20 ملجم مرة واحدة يوميا لمدة 4-8 أسابيع.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لمنع قرحة الإثنى عشر والمعدة</strong> إذا كنت تتناول مضادات الالتهاب غير الستيروئيدية:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 20 ملجم مرة واحدة يوميا.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">لعلاج <strong>القرح التي تسببها عدوى هيليكوباكتر بيلوري</strong> ومنع عودتها:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 20 ملجم أوميبرازول مرتين يوميا لمدة أسبوع واحد.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طبيبك سوف يقول لك أيضا أن تتناول اثنين من المضادات الحيوية بين أموكسيسيلين، كلاريثروميسين وميترونيدازول.</li></ul><p dir="RTL">لعلاج كثرة الحمض في المعدة الناجمة <strong>عن النمو في البنكرياس (متلازمة زولينجر إليسون):</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الجرعة المعتادة هي 60 ملجم يوميا.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طبيبك سوف يعدل الجرعة اعتمادا على الاحتياجات الخاصة بك وسوف يقرر أيضا كم من الوقت تحتاج لأن تتناول هذا الدواء.</li></ul><p dir="RTL"><u>الاستخدام في الأطفال</u></p><p dir="RTL">لعلاج أعراض GERD مثل <strong>الحرقة وارتجاع الحمض</strong>:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; الأطفال أكثر من 1 سنة من العمر ومع وزن الجسم أكثر من 10 كجم من الممكن تناول أوميبرازول. تستند الجرعة للأطفال على وزن الطفل والطبيب سوف يقرر الجرعة الصحيحة.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لعلاج القرحة التي سببها عدوى &quot;هيليكوباكتر بيلوري&quot; ومنع عودتها</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الأطفال الذين تزيد أعمارهم عن 4 سنوات من الممكن تناول أوميبرازول. تستند الجرعة للأطفال على وزن الطفل والطبيب سوف يقرر الجرعة الصحيحة.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; طبيبك سوف يصف أيضا اثنين من المضادات الحيوية تسمى أموكسيسيلين وكلاريثروميسين لطفلك.<strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>&nbsp;</strong><strong>تناول هذا الدواء</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;من الموصى به أن تتناول الكبسولات في الصباح.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;يمكنك أن تتناول الكبسولات الخاصة بك مع الطعام أو على معدة فارغة.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إبتلع الكبسولات الخاصة بك كلها مع نصف كوب من الماء. لا تمضغ أو تسحق الكبسولات. وذلك لأن الكبسولات تحتوي على حبيبات مغلفة التي تمنع تحلل الدواء بسبب الحمض الموجود في المعدة. من المهم عدم تكسير الكريات.<strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>ماذا تفعل إذا واجهت أنت أو طفلك صعوبة في ابتلاع الكبسولات</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا واجهت أنت أو طفلك صعوبة في بلع الكبسولات:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; افتح الكبسولات وابتلع المحتويات مباشرة مع نصف كوب من الماء أو ضع المحتويات في كوب من مياه معبأة (غير الغازية)، أو عصير فواكه حمضية (مثل التفاح والبرتقال أو الأناناس) أو صلصة التفاح.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دائما قم بتقليب الخليط جيدا قبل شربه لأن الخليط لن يكون شفافاً. ثم اشرب هذا الخليط على الفور أو في غضون 30 دقيقة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; للتأكد من أنك شربت كل الدواء، اشطف الكوب بشكل جيد جدا مع نصف كوب من الماء واشربه. القطع الصلبة تحتوي على الدواء &ndash; لا تمضغها أو تسحقها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا تناولت كبسولات جاستروزول أكثر مما يجب</strong></p><p dir="RTL">إذا تناولت المزيد من كبسولات جاستروزول أكثر مما وصفه الطبيب، تحدث مع طبيبك أو الصيدلي فورا.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اذا نسيت أن تتناول كبسولات جاستروزول </strong></p><p dir="RTL">إذا نسيت أن تتناول جرعة، تناولها حالما تتذكر ذلك. ومع ذلك، إذا كان الوقت قريبا لتناول الجرعة التالية فتجاوز الجرعة المنسية. لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL"><strong>إذا كان لديك أي أسئلة أخرى حول استخدام هذا المنتج ، اسأل الطبيب أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن لكبسولات جاستروزول أن تسبب آثاراً جانبية، على الرغم من أن الجميع لا يحدث لهم ذلك.</p><p dir="RTL"><strong>إذا لاحظت أي من الآثار الجانبية التالية، النادرة ولكنها خطيرة توقف عن تناول جاستروزول كبسولات واتصل بطبيب فورا</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الصفير المفاجئ عند التنفس، وتورم في الشفتين واللسان والحلق أو الجسم، والطفح الجلدي، والاغماء أو صعوبات في البلع (رد فعل تحسسي شديد).</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>احمرار في الجلد مع ظهور بثور أو تقشير. قد يكون هناك بثور حادة ونزيف في الشفاه والعينين والفم والأنف والأعضاء التناسلية &ndash; وهذا يمكن أن يكون &quot; متلازمة ستيفنز جونسون&quot; أو &quot;انحلال البشرة السمي&quot;.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>البشرة الصفراء والبول الداكن والتعب الذي يمكن أن يكون أعراض لمشكلات في الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية الأخرى:</p><p dir="RTL"><strong>الآثار الجانبية الشائعة (قد توثر في ما يصل الى 1 من 10 أشخاص)</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; الصداع.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;التأثيرات على المعدة أو الأمعاء: الإسهال، وآلام في المعدة، والإمساك، والرياح (انتفاخ البطن).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; الشعور بالمرض (الغثيان) أو أن تكون مريضا (التقيؤ).<strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>الآثار الجانبية غير الشائعة ( قد تؤثر في ما يصل الى 1 من 100 شخص)</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تورم في القدمين والكاحلين.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;اضطراب في النوم (الأرق).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الدوخة، الاحساس بوخز مثل &quot;الإبر والدبابيس&quot;، والشعور بالنعاس.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;شعور بدوخة (الدوار).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; التغييرات في اختبارات الدم التي تتحقق من كيفية عمل الكبد.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طفح الجلد، والطفح الجلدي العقدي (الاحمرار) وحكة في الجلد.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; توعك عام وافتقار إلى الطاقة.</li></ul><p dir="RTL"><strong>الآثار الجانبية النادرة( قد تؤثر في ما يصل الى 1 من 1000 شخص)</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مشاكل الدم مثل انخفاض عدد الخلايا البيضاء أو الصفائح الدموية. هذا يمكن أن يسبب ضعف، وكدمات أو جعل العدوى أكثر احتمالا.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ردود فع تحسسية، أحيانا شديدة جدا، بما في ذلك تورم في الشفتين واللسان والحلق، والحمى، وصفير التنفس.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;انخفاض مستويات الصوديوم في الدم. قد يسبب هذا الضعف، والشعور بالمرض (القيء) وتشنجات.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;الشعور بالاستثارة، و الارتباك أو الاكتئاب.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تغييرات بحاسة طعم.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مشاكل البصر مثل تشوش الرؤية.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; الشعور فجأة أن التنفس ذو أزيز أو ضيق (تشنج قصبي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;جفاف الفم.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;التهاب داخل الفم.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;عدوى تسمى &quot;القلاع&quot; التي يمكن أن تؤثر على الأمعاء ويسببه نوع من الفطريات.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مشاكل الكبد، بما في ذلك اليرقان الذي يمكن أن يسبب البشرة الصفراء والبول الداكن، والتعب.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تساقط الشعر (الصلع).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طفح الجلد عند التعرض لأشعة الشمس.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;آلام في المفاصل (ألم مفصلي) أو آلام العضلات (ألم عضلي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مشاكل شديدة في الكلى (التهاب الكلية الخلالي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;زيادة التعرق.<strong>&nbsp;</strong></li><li><strong>الآثار الجانبية النادرة جدا( قد تؤثر في ما يصل الى 1 من 10000 شخص)</strong></li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تغيرات في تعداد الدم بما في ذلك ندرة المحببات (عدم وجود خلايا الدم البيضاء).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;العدوانية.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; مشاهدة، أو شعور أو سماع أشياء ليست موجودة (الهلوسة).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مشاكل شديدة في الكبد مما يؤدي إلى فشل الكبد والتهاب الدماغ.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طفح جلدي شديد مفاجئ أو بتور بالجلد أو تقشير. هذا قد يترافق مع ارتفاع في درجة الحرارة وآلام في المفاصل (حمامي عديدة الأشكال، متلازمة ستيفن جونسون، انحلال البشرة السمي).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ضعف العضلات.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;تضخم الثدي لدى الرجال.</li><li><strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>غير معروفة (التكرار غير محدد من المعلومات المتاحة)</strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;التهاب في القناة الهضمية (مما يؤدي إلى الإسهال).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;إذا كنت تتناول أوميبرازول لأكثر من ثلاثة أشهر من الممكن أن مستويات المغنيسيوم في الدم قد تنخفض. ويمكن رؤية مستويات منخفضة من المغنيسيوم على شكل تعب، تقلصات العضلات اللاإرادية، والارتباك، والتشنجات، والدوخة، وزيادة معدل ضربات القلب. إذا كان لديك أي من هذه الأعراض، من فضلك أخبر طبيبك فورا. المستويات المنخفضة من المغنيسيوم يمكن أن تؤدي أيضا إلى انخفاض في مستويات البوتاسيوم أو الكالسيوم في الدم. طبيبك قد يقرر إجراء اختبارات الدم العادية لرصد مستويات المغنيسيوم.</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;طفح ، من المحتمل مع ألم في المفاصل</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">قد تؤثر كبسولات جاستروزول في حالات نادرة جدا على خلايا الدم البيضاء مما يؤدي إلى نقص المناعة.</p><p dir="RTL">إذا كان لديك عدوى مع أعراض مثل الحمى مع انخفاض حاد في الحالة العامة أو حمى مع أعراض عدوى محلية مثل آلام في الرقبة والحلق أو الفم أو صعوبات في التبول، عليك استشارة الطبيب في أقرب وقت ممكن حتى يمكن استبعاد نقص في خلايا الدم البيضاء (ندرة المحببات) من خلال اختبار الدم. من المهم بالنسبة لك أن تعطي المعلومات عن الأدوية الخاص بك في هذا الوقت.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا اصبحت أي آثار جانبية خطيرة، أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي.</strong></p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في العبوة الأصلية للحماية من الضوء والرطوبة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم جاستروزول كبسولات بعد تاريخ انتهاء الصلاحية التي ذكرت على العبوة بعد &quot;EXP&quot;. تاريخ انتهاء الصلاحية يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب ألا يتم التخلص من الأدوية من خلال مياه الصرف الصحي أو النفايات المنزلية. أسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. سوف تساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا تحتوي كبسولات جاستروزول </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;المادة الفعالة هي: كل كبسولة جاستروزول تحتوي على كريات أوميبرازول 8,5 % (20 ملجم).</li><li>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;قشرة الكبسولة: RC 14 &nbsp;(مقاس 2)<strong>&nbsp;</strong></li></ul><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف تبدو كبسولة جاستروزول ومحتويات العبوة:</strong></p><p dir="RTL">كبسولة جسمها رمادي معتم وغطاؤها اخضر غامق اللون ومطبوع عليها باللون الأبيض RP 14 وتحتوي على كريات مغلفة معوياً لونها أبيض لالى أبيض داكن .</p><p dir="RTL">العبوة تحتوي على 14 كبسولة في قارورة بيضاء .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة المنتجات الطبية والتجميلية المحدودة ( الرياض فارما)</p><p dir="RTL">ص.ب. 442 الرياض 11411</p><p dir="RTL">فاكس: 966112650505+</p><p dir="RTL">البريد الإلكتروني: contact@riyadhpharma.com</p><p dir="RTL"><em>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على&nbsp; صاحب الترخيص والتسويق:</em></p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">قسم التسويق</p><p dir="RTL">الرياض</p><p dir="RTL">تلفون: 966112650111+</p><p dir="RTL">البريد الإلكتروني: marketing@riyadhpharma.com</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            8/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastrozole 20 mg hard gastro-resistant capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains 20 mg omeprazole.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro-resistant capsule, hard (gastro-resistant capsule).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrozole capsules are indicated for:<br />Adults<br />&bull; Treatment of duodenal ulcers<br />&bull; Prevention of relapse of duodenal ulcers<br />&bull; Treatment of gastric ulcers<br />&bull; Prevention of relapse of gastric ulcers<br />&bull; In combination with appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease<br />&bull; Treatment of NSAID-associated gastric and duodenal ulcers<br />&bull; Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk<br />&bull; Treatment of reflux oesophagitis<br />&bull; Long-term management of patients with healed reflux oesophagitis<br />&bull; Treatment of symptomatic gastro-oesophageal reflux disease<br />&bull; Treatment of Zollinger-Ellison syndrome<br />Paediatric use<br />Children over 1 year of age and  10 kg<br />&bull; Treatment of reflux oesophagitis<br />&bull; Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease</p><p>Children and adolescents over 4 years of age<br />&bull; In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><strong><em><u>Adults</u></em></strong></p><p><strong>&nbsp;</strong></p><p><strong><em>Treatment of duodenal ulcers</em></strong></p><p>The recommended dose in patients with an active duodenal ulcer is Gastrozole 20 mg once daily. In most patients healing occurs within two weeks. For those patients who may not be fully healed after the initial course, healing usually occurs during a further two weeks treatment period. In patients with poorly responsive duodenal ulcer Gastrozole 40 mg once daily is recommended and healing is usually achieved within four weeks.</p><p><strong><em>Prevention of relapse of duodenal ulcers</em></strong></p><p>For the prevention of relapse of duodenal ulcer in&nbsp;<em>H. pylori</em>&nbsp;negative patients or when&nbsp;<em>H. pylori</em>&nbsp;eradication is not possible the recommended dose is Gastrozole 20 mg once daily. In some patients a daily dose of 10 mg may be sufficient. In case of therapy failure, the dose can be increased to 40 mg.</p><p><strong><em>Treatment of gastric ulcers</em></strong></p><p>The recommended dose is Gastrozole 20 mg once daily. In most patients healing occurs within four weeks. For those patients who may not be fully healed after the initial course, healing usually occurs during a further four weeks treatment period. In patients with poorly responsive gastric ulcer Gastrozole 40 mg once daily is recommended and healing is usually achieved within eight weeks.</p><p><strong><em>Prevention of relapse of gastric ulcers</em></strong></p><p>For the prevention of relapse in patients with poorly responsive gastric ulcer the recommended dose is Gastrozole 20 mg once daily. If needed the dose can be increased to Gastrozole 40 mg once daily.</p><p><strong><em>H. pylori eradication in peptic ulcer disease</em></strong></p><p>For the eradication of&nbsp;<em>H. pylori</em>&nbsp;the selection of antibiotics should consider the individual patient&#39;s drug tolerance, and should be undertaken in accordance with national, regional and local resistance patterns and treatment guidelines.</p><p>&bull; Gastrozole 20 mg + clarithromycin 500 mg + amoxicillin 1,000 mg, each twice daily for one week, or</p><p>&bull; Gastrozole 20 mg + clarithromycin 250 mg (alternatively 500 mg) + metronidazole 400 mg (or 500 mg or tinidazole 500 mg), each twice daily for one week or</p><p>&bull; Gastrozole 40 mg once daily with amoxicillin 500 mg and metronidazole 400 mg (or 500 mg or tinidazole 500 mg), both three times a day for one week.</p><p>In each regimen, if the patient is still&nbsp;<em>H. pylori</em>&nbsp;positive, therapy may be repeated.</p><p><strong><em>Treatment of NSAID-associated gastric and duodenal ulcers</em></strong></p><p>For the treatment of NSAID<em>-</em>associated gastric and duodenal ulcers, the recommended dose is Gastrozole 20 mg once daily. In most patients healing occurs within four weeks. For those patients who may not be fully healed after the initial course, healing usually occurs during a further four weeks treatment period.</p><p><strong><em>Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk</em></strong></p><p>For the prevention of NSAID<em>-</em>associated gastric ulcers or duodenal ulcers in patients at risk (age&gt; 60, previous history of gastric and duodenal ulcers, previous history of upper GI bleeding) the recommended dose is Gastrozole 20 mg once daily.</p><p><strong><em>Treatment of reflux oesophagitis</em></strong></p><p>The recommended dose is Gastrozole 20 mg once daily. In most patients healing occurs within four weeks. For those patients who may not be fully healed after the initial course, healing usually occurs during a further four weeks treatment period.</p><p>In patients with severe oesophagitis Gastrozole 40 mg once daily is recommended and healing is usually achieved within eight weeks.</p><p><strong><em>Long-term management of patients with healed reflux oesophagitis</em></strong></p><p>For the long-term management of patients with healed reflux oesophagitis the recommended dose is Gastrozole 10 mg once daily. If needed, the dose can be increased to Gastrozole 20-40 mg once daily.</p><p><strong><em>Treatment of symptomatic gastro-oesophageal reflux disease</em></strong></p><p>The recommended dose is Gastrozole 20 mg daily. Patients may respond adequately to 10 mg daily, and therefore individual dose adjustment should be considered.</p><p>If symptom control has not been achieved after four weeks treatment with Gastrozole 20 mg daily, further investigation is recommended.</p><p><strong><em>Treatment of Zollinger-Ellison syndrome</em></strong></p><p>In patients with Zollinger-Ellison syndrome the dose should be individually adjusted and treatment continued as long as clinically indicated. The recommended initial dose is Gastrozole 60 mg daily. All patients with severe disease and inadequate response to other therapies have been effectively controlled and more than 90% of the patients maintained on doses of Gastrozole 20-120 mg daily. When dose exceed Gastrozole 80 mg daily, the dose should be divided and given twice daily.</p><p><strong><em><u>Paediatric population</u></em></strong></p><p><em><u>Children over 1 year of age and &ge; 10 kg</u></em></p><p><em>Treatment of reflux oesophagitis</em></p><p><em>Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease</em></p><p>The posology recommendations are as follows:</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p>Age</p></td><td style="vertical-align:top"><p>Weight</p></td><td style="vertical-align:top"><p>Posology</p></td></tr><tr><td style="vertical-align:top"><p>&ge; 1 year of age</p></td><td style="vertical-align:top"><p>10-20 kg</p></td><td style="vertical-align:top"><p>10 mg once daily. The dose can be increased to 20 mg once daily if needed</p></td></tr><tr><td style="vertical-align:top"><p>&ge; 2 years of age</p></td><td style="vertical-align:top"><p>&gt; 20 kg</p></td><td style="vertical-align:top"><p>20 mg once daily. The dose can be increased to 40 mg once daily if needed</p></td></tr></tbody></table><p><em>Reflux oesophagitis</em>: The treatment time is 4-8 weeks.</p><p><em>Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease:</em>&nbsp;The treatment time is 2&ndash;4 weeks. If symptom control has not been achieved after 2&ndash;4 weeks the patient should be investigated further.</p><p><em><u>Children and adolescents over 4 years of age</u></em></p><p><em>Treatment of duodenal ulcer caused by H. pylori</em></p><p>When selecting appropriate combination therapy, consideration should be given to official national, regional and local guidance regarding bacterial resistance, duration of treatment (most commonly 7 days but sometimes up to 14 days), and appropriate use of antibacterial agents.</p><p>The treatment should be supervised by a specialist.</p><p>The posology recommendations are as follows:</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p>Weight</p></td><td style="vertical-align:top"><p>Posology</p></td></tr><tr><td style="vertical-align:top"><p>15&ndash;30 kg</p></td><td style="vertical-align:top"><p>Combination with two antibiotics: Gastrozole 10 mg, amoxicillin 25 mg/kg body weight and clarithromycin 7.5 mg/kg body weight are all administrated together two times daily for one week.</p></td></tr><tr><td style="vertical-align:top"><p>31&ndash;40 kg</p></td><td style="vertical-align:top"><p>Combination with two antibiotics: Gastrozole 20 mg, amoxicillin 750 mg and clarithromycin 7.5 mg/kg body weight are all administrated two times daily for one week.</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 40 kg</p></td><td style="vertical-align:top"><p>Combination with two antibiotics: Gastrozole 20 mg, amoxicillin 1 g and clarithromycin 500 mg are all administrated two times daily for one week.</p></td></tr></tbody></table><p><strong><em><u>Special populations</u></em></strong></p><p><em>Renal impairment</em></p><p>Dose adjustment is not needed in patients with impaired renal function (see section 5.2).</p><p><strong><em>Hepatic impairment</em></strong></p><p>In patients with impaired hepatic function a daily dose of 10&ndash;20 mg may be sufficient (see section 5.2).</p><p><strong><em>Elderly</em></strong></p><p>Dose adjustment is not needed in the elderly (see section 5.2).</p><p><strong><u>Method of administration</u></strong></p><p>It is recommended to take Gastrozole capsules in the morning, swallowed whole with half a glass of water. The capsules must not be chewed or crushed.</p><p><strong><em>For patients with swallowing difficulties and for children who can drink or swallow semi-solid food</em></strong></p><p>Patients can open the capsule and swallow the contents with half a glass of water or after mixing the contents in a slightly acidic fluid e.g., fruit juice or applesauce, or in non-carbonated water. Patients should be advised that the dispersion should be taken immediately (or within 30 minutes) and always be stirred just before drinking and rinsed down with half a glass of water.</p><p>Alternatively patients can suck the capsule and swallow the pellets with half a glass of water. The enteric-coated pellets must not be chewed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, substituted benzimidazoles or to any of the excipients listed in section 6.1.
Omeprazole like other proton pump inhibitors (PPIs) must not be used concomitantly with nelfinavir (see section 4.5).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the presence of any alarm symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melena) and when gastric ulcer is suspected or present, malignancy should be excluded, as treatment may alleviate symptoms and delay diagnosis.</p><p>Co-administration of atazanavir with proton pump inhibitors is not recommended (see section 4.5). If the combination of atazanavir with a proton pump inhibitor is judged unavoidable, close clinical monitoring (e.g. virus load) is recommended in combination with an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir; omeprazole 20 mg should not be exceeded.</p><p>Omeprazole, as all acid-blocking medicines, may reduce the absorption of vitamin B<sub>12</sub>&nbsp;(cyanocobalamin) due to hypo- or achlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B<sub>12</sub>absorption on long-term therapy.</p><p>Omeprazole is a CYP2C19 inhibitor. When starting or ending treatment with omeprazole, the potential for interactions with drugs metabolised through CYP2C19 should be considered. An interaction is observed between clopidogrel and omeprazole (see section 4.5). The clinical relevance of this interaction is uncertain. As a precaution, concomitant use of omeprazole and clopidogrel should be discouraged.</p><p>Severe hypomagnesaemia has been reported in patients treated with proton pump inhibitors (PPIs) like omeprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.</p><p>For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs that may cause hypomagnesaemia (e.g. diuretics), healthcare professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment.</p><p>Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10-40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium.</p><p><u>Subacute cutaneous lupus erythematosus (SCLE)</u></p><p>Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Gastrozole. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p><u>Interference with laboratory tests</u></p><p>Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, omeprazole treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.</p><p>Some children with chronic illnesses may require long-term treatment although it is not recommended.</p><p>Gastrozole contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>Treatment with proton pump inhibitors may lead to slightly increased risk of gastrointestinal infections such as&nbsp;<em>Salmonella</em>&nbsp;and&nbsp;<em>Campylobacter</em>&nbsp;and, in hospitalised patients, possibly also&nbsp;<em>Clostridium difficile</em>&nbsp;(see section 5.1).</p><p>As in all long-term treatments, especially when exceeding a treatment period of 1 year, patients should be kept under regular surveillance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effects of omeprazole on the pharmacokinetics of other active substances</u></p><p><em><u>Active substances with pH dependent absorption</u></em></p><p>The decreased intragastric acidity during treatment with omeprazole might increase or decrease the absorption of active substances with a gastric pH dependent absorption.</p><p><strong><em>Nelfinavir, atazanavir</em></strong></p><p>The plasma levels of nelfinavir and atazanavir are decreased in case of co-administration with omeprazole.</p><p>Concomitant administration of omeprazole with nelfinavir is contraindicated (see section 4.3). Co-administration of omeprazole (40 mg once daily) reduced mean nelfinavir exposure by ca. 40% and the mean exposure of the pharmacologically active metabolite M8 was reduced by ca. 75 &ndash;90%. The interaction may also involve CYP2C19 inhibition.</p><p>Concomitant administration of omeprazole with atazanavir is not recommended (see section 4.4). Concomitant administration of omeprazole (40 mg once daily) and atazanavir 300 mg/ritonavir 100 mg to healthy volunteers resulted in a 75% decrease of the atazanavir exposure. Increasing the atazanavir dose to 400 mg did not compensate for the impact of omeprazole on atazanavir exposure. The co-administration of omeprazole (20 mg once daily) with atazanavir 400 mg/ritonavir 100 mg to healthy volunteers resulted in a decrease of approximately 30% in the atazanavir exposure as compared to atazanavir 300 mg/ritonavir 100 mg once daily.</p><p><strong><em>Digoxin</em></strong></p><p>Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10%. Digoxin toxicity has been rarely reported. However caution should be exercised when omeprazole is given at high doses in elderly patients. Therapeutic drug monitoring of digoxin should be then be reinforced.</p><p><strong><em>Clopidogrel</em></strong></p><p>Results from studies in healthy subjects have shown a pharmacokinetic (PK)/pharmacodynamic (PD) interaction between clopidogrel (300 mg loading dose/75 mg daily maintenance dose) and omeprazole (80 mg p.o. daily) resulting in a decreased exposure to the active metabolite of clopidogrel by an average of 46% and a decreased maximum inhibition of (ADP induced) platelet aggregation by an average of 16%.</p><p>Inconsistent data on the clinical implications of a PK/PD interaction of omeprazole in terms of major cardiovascular events have been reported from both observational and clinical studies. As a precaution, concomitant use of omeprazole and clopidogrel should be discouraged (see section 4.4).</p><p><strong><em>Other active substances</em></strong></p><p>The absorption of posaconazole, erlotinib, ketoconazole and itraconazole is significantly reduced and thus clinical efficacy may be impaired. For posaconazole and erlotinib concomitant use should be avoided.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Active substances metabolised by CYP2C19</u></em></p><p>Omeprazole is a moderate inhibitor of CYP2C19, the major omeprazole metabolising enzyme. Thus, the metabolism of concomitant active substances also metabolised by CYP2C19, may be decreased and the systemic exposure to these substances increased. Examples of such drugs are R-warfarin and other vitamin K antagonists, cilostazol, diazepam and phenytoin.</p><p><strong><em>Cilostazol</em></strong></p><p>Omeprazole, given in doses of 40 mg to healthy subjects in a cross-over study, increased C<sub>max&nbsp;</sub>and AUC for cilostazol by 18% and 26% respectively, and one of its active metabolites by 29% and 69% respectively.</p><p><strong><em>Phenytoin</em></strong></p><p>Monitoring phenytoin plasma concentration is recommended during the first two weeks after initiating omeprazole treatment and, if a phenytoin dose adjustment is made, monitoring and a further dose adjustment should occur upon ending omeprazole treatment.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Unknown mechanism</u></em></p><p><strong><em>Saquinavir</em></strong></p><p>Concomitant administration of omeprazole with saquinavir/ritonavir resulted in increased plasma levels up to approximately 70% for saquinavir associated with good tolerability in HIV-infected patients.</p><p><strong><em>Methotrexate</em></strong></p><p>When given together with proton-pump inhibitors, methotrexate levels have been reported to increase in some patients. In high-dose methotrexate administration a temporary withdrawal of omeprazole may need to be considered.</p><p><strong><em>Tacrolimus</em></strong></p><p>Concomitant administration of omeprazole has been reported to increase the serum levels of tacrolimus. A reinforced monitoring of tacrolimus concentrations as well as renal function (creatinine clearance) should be performed, and dosage of tacrolimus adjusted if needed.</p><p><u>Effects of other active substances on the pharmacokinetics of omeprazole</u></p><p><em><u>Inhibitors of CYP2C19 and/or CYP3A4</u></em></p><p>Since omeprazole is metabolised by CYP2C19 and CYP3A4, active substances known to inhibit CYP2C19 or CYP3A4 (such as clarithromycin and voriconazole) may lead to increased omeprazole serum levels by decreasing omeprazole&#39;s rate of metabolism. Concomitant voriconazole treatment resulted in more than doubling of the omeprazole exposure. As high doses of omeprazole have been well-tolerated adjustment of the omeprazole dose is not generally required. However, dose adjustment should be considered in patients with severe hepatic impairment and if long-term treatment is indicated.</p><p><em><u>Inducers of CYP2C19 and/or CYP3A4</u></em></p><p>Active substances known to induce CYP2C19 or CYP3A4 or both (such as rifampicin and St John&#39;s wort) may lead to decreased omeprazole serum levels by increasing omeprazole&#39;s rate of metabolism.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Results from three prospective epidemiological studies (more than 1000 exposed outcomes) indicate no adverse effects of omeprazole on pregnancy or on the health of the foetus/newborn child. Omeprazole can be used during pregnancy.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Omeprazole is excreted in breast milk but is not likely to influence the child when therapeutic doses are used.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrozole is not likely to affect the ability to drive or use machines. Adverse drug reactions such as dizziness and visual disturbances may occur (see section 4.8). If affected, patients should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>The most common side effects (1-10% of patients) are headache, abdominal pain, constipation, diarrhoea, flatulence and nausea/vomiting.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p>The following adverse drug reactions have been identified or suspected in the clinical trials programme for omeprazole and post-marketing. None was found to be dose-related. Adverse reactions listed below are classified according to frequency and System Organ Class (SOC). Frequency categories are defined according to the following convention: Very common (&ge; 1/10), Common (&ge; 1/100 to &lt; 1/10), Uncommon (&ge; 1/1,000 to &lt; 1/100), Rare (&ge; 1/10,000 to &lt; 1/1,000), Very rare (&lt; 1/10,000), Not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>SOC/frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Leukopenia, thrombocytopenia</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Agranulocytosis, pancytopenia</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions e.g. fever, angioedema and anaphylactic reaction/shock</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hyponatraemia</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>Hypomagnesaemia; severe hypomagnesaemia may result in hypocalcaemia.</p><p>Hypomagnesaemia may also be associated with hypokalaemia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Insomnia</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Agitation, confusion, depression</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Aggression, hallucinations</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Headache</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Dizziness, paraesthesia, somnolence</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Taste disturbance</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Blurred vision</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Vertigo</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Bronchospasm</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Dry mouth, stomatitis, gastrointestinal candidiasis</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>Microscopic colitis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Increased liver enzymes</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hepatitis with or without jaundice</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Hepatic failure, encephalopathy in patients with pre-existing liver disease</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Dermatitis, pruritus, rash, urticaria</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Alopecia, photosensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>Subacute cutaneous lupus erythematosus (see section 4.4)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Musculoskeletal and connective tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Fracture of the hip, wrist or spine</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Arthralgia, myalgia</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Muscular weakness</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Interstitial nephritis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Gynaecomastia</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Malaise, peripheral oedema</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Increased sweating</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p><u>Paediatric population</u></p><p>The safety of omeprazole has been assessed in a total of 310 children aged 0 to 16 years with acid-related disease. There are limited long term safety data from 46 children who received maintenance therapy of omeprazole during a clinical study for severe erosive oesophagitis for up to 749 days. The adverse event profile was generally the same as for adults in short- as well as in long-term treatment. There are no long term data regarding the effects of omeprazole treatment on puberty and growth.</p><p>&nbsp;</p><p>&nbsp;<strong>To report any side effects</strong></p><p>- National Pharmacovigilance and Drug Safety Center (NPC)</p><p>oFax: +966-11-205-7662</p><p>oTo call the executive management of vigilance and crisis management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</p><p>oToll-free: 8002490000</p><p>oE-mail: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is limited information available on the effects of overdoses of omeprazole in humans. In the literature, doses of up to 560 mg have been described, and occasional reports have been received when single oral doses have reached up to 2,400 mg omeprazole (120 times the usual recommended clinical dose). Nausea, vomiting, dizziness, abdominal pain, diarrhoea and headache have been reported. Also apathy, depression and confusion have been described in single cases.</p><p>The symptoms described have been transient, and no serious outcome has been reported. The rate of elimination was unchanged (first order kinetics) with increased doses. Treatment, if needed, is symptomatic.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Drugs for acid-related disorders, proton pump inhibitors, ATC code: A02BC01</p><p><u>&nbsp;</u></p><p><strong><u>Mechanism of action</u></strong></p><p>Omeprazole, a racemic mixture of two enantiomers<strong>&nbsp;</strong>reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.</p><p>Omeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the intracellular canaliculi within the parietal cell, where it inhibits the enzyme H<sup>+</sup>&nbsp;K<sup>+</sup>-ATPase - the acid pump. This effect on the final step of the gastric acid formation process is dose-dependent and provides for highly effective inhibition of both basal acid secretion and stimulated acid secretion, irrespective of stimulus.</p><p><u>&nbsp;</u></p><p><strong><u>Pharmacodynamic effects</u></strong></p><p>All pharmacodynamic effects observed can be explained by the effect of omeprazole on acid secretion.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Effect on gastric acid secretion</u></em></p><p>Oral dosing with omeprazole once daily provides for rapid and effective inhibition of daytime and night-time gastric acid secretion with maximum effect being achieved within 4 days of treatment. With omeprazole 20 mg, a mean decrease of at least 80% in 24-hour intragastric acidity is then maintained in duodenal ulcer patients, with the mean decrease in peak acid output after pentagastrin stimulation being about 70% 24 hours after dosing.</p><p>Oral dosing with omeprazole 20 mg maintains an intragastric pH of &ge; 3 for a mean time of 17 hours of the 24-hour period in duodenal ulcer patients.</p><p>As a consequence of reduced acid secretion and intragastric acidity, omeprazole dose-dependently reduces/normalizes acid exposure of the oesophagus in patients with gastro-oesophageal reflux disease.</p><p>The inhibition of acid secretion is related to the area under the plasma concentration-time curve (AUC) of omeprazole and not to the actual plasma concentration at a given time.</p><p>No tachyphylaxis has been observed during treatment with omeprazole.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Effect on H. pylori</u></em></p><p><em>H. pylori</em>&nbsp;is associated with peptic ulcer disease, including duodenal and gastric ulcer disease.&nbsp;<em>H. pylori</em>&nbsp;is a major factor in the development of gastritis.&nbsp;<em>H. pylori</em>&nbsp;together with gastric acid are major factors in the development of peptic ulcer disease.&nbsp;<em>H. pylori</em>&nbsp;is a major factor in the development of atrophic gastritis which is associated with an increased risk of developing gastric cancer.</p><p>Eradication of&nbsp;<em>H. pylori</em>&nbsp;with omeprazole and antimicrobials is associated with, high rates of healing and long-term remission of peptic ulcers.</p><p>Dual therapies have been tested and found to be less effective than triple therapies. They could, however, be considered in cases where known hypersensitivity precludes use of any triple combination.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Other effects related to acid inhibition</u></em></p><p>During long-term treatment gastric glandular cysts have been reported in a somewhat increased frequency. These changes are a physiological consequence of pronounced inhibition of acid secretion, are benign and appear to be reversible.</p><p>Decreased gastric acidity due to any means including proton pump inhibitors, increases gastric counts of bacteria normally present in the gastrointestinal tract. Treatment with acid-reducing drugs may lead to slightly increased risk of gastrointestinal infections such as&nbsp;<em>Salmonella</em>&nbsp;and&nbsp;<em>Campylobacter</em>&nbsp;and, in hospitalised patients, possibly also&nbsp;<em>Clostridium difficile.</em></p><p>During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level may interfere with investigations for neuroendocrine tumours. Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously elevated following PPI treatment to return to reference range.</p><p>An increased number of ECL cells possibly related to the increased serum gastrin levels, have been observed in some patients (both children and adults) during long term treatment with omeprazole. The findings are considered to be of no clinical significance.</p><p><u>&nbsp;</u></p><p><u>Paediatric population</u></p><p>In a non-controlled study in children (1 to 16 years of age) with severe reflux oesophagitis, omeprazole at doses of 0.7 to 1.4 mg/kg improved oesophagitis level in 90% of the cases and significantly reduced reflux symptoms. In a single-blind study, children aged 0&ndash;24 months with clinically diagnosed gastro-oesophageal reflux disease were treated with 0.5, 1.0 or 1.5 mg omeprazole/kg. The frequency of vomiting/regurgitation episodes decreased by 50% after 8 weeks of treatment irrespective of the dose.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Eradication of H. pylori in children</u></em></p><p>A randomised, double blind clinical study (H&eacute;liot study) concluded that omeprazole in combination with two antibiotics (amoxicillin and clarithromycin), was safe and effective in the treatment of&nbsp;<em>H. pylori</em>&nbsp;infection in children age 4 years old and above with gastritis:&nbsp;<em>H. pylori&nbsp;</em>eradication rate: 74.2% (23/31 patients) with omeprazole + amoxicillin + clarithromycin versus 9.4% (3/32 patients) with amoxicillin + clarithromycin. However, there was no evidence of any clinical benefit with respect to dyspeptic symptoms. This study does not support any information for children aged less than 4 years.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Omeprazole and omeprazole magnesium are acid labile and are therefore administered orally as enteric-coated granules in capsules or tablets. Absorption of omeprazole is rapid, with peak plasma levels occurring approximately 1-2 hours after dose. Absorption of omeprazole<strong>&nbsp;</strong>takes place in the small intestine and is usually completed within 3-6 hours. Concomitant intake of food has no influence on the bioavailability. The systemic availability (bioavailability) from a single oral dose of omeprazole is approximately 40%. After repeated once-daily administration, the bioavailability increases to about 60%.</p><p><u>&nbsp;</u></p><p><u>Distribution</u></p><p>The apparent volume of distribution in healthy subjects is approximately 0.3 l/kg body weight. Omeprazole is 97% plasma protein bound.</p><p><u>&nbsp;</u></p><p><u>Biotransformation</u></p><p>Omeprazole is completely metabolised by the cytochrome P450 system (CYP). The major part of its metabolism is dependent on the polymorphically expressed CYP2C19, responsible for the formation of hydroxyomeprazole, the major metabolite in plasma. The remaining part is dependent on another specific isoform, CYP3A4, responsible for the formation of omeprazole sulfone. As a consequence of high affinity of omeprazole to CYP2C19, there is a potential for competitive inhibition and metabolic drug-drug interactions with other substrates for CYP2C19. However, due to low affinity to CYP3A4, omeprazole has no potential to inhibit the metabolism of other CYP3A4 substrates. In addition, omeprazole lacks an inhibitory effect on the main CYP enzymes.</p><p>Approximately 3% of the Caucasian population and 15-20% of Asian populations lack a functional CYP2C19 enzyme and are called poor metabolisers. In such individuals the metabolism of omeprazole is probably mainly catalysed by CYP3A4. After repeated once-daily administration of 20 mg omeprazole, the mean AUC was 5 to 10 times higher in poor metabolisers than in subjects having a functional CYP2C19 enzyme (extensive metabolisers). Mean peak plasma concentrations were also higher, by 3 to 5 times. These findings have no implications for the posology of omeprazole.</p><p><u>&nbsp;</u></p><p><u>Elimination</u></p><p>The plasma elimination half-life of omeprazole is usually shorter than one hour both after single and repeated oral once-daily dosing. Omeprazole is completely eliminated from plasma between doses with no tendency for accumulation during once-daily administration. Almost 80% of an oral dose of omeprazole is excreted as metabolites in the urine, the remainder in the faeces, primarily originating from bile secretion.</p><p>Linearity/non-linearity</p><p>The AUC of omeprazole increases with repeated administration. This increase is dose-dependent and results in a non-linear dose-AUC relationship after repeated administration. This time- and dose-dependency is due to a decrease of first pass metabolism and systemic clearance probably caused by an inhibition of the CYP2C19 enzyme by omeprazole and/or its metabolites (e.g. the sulfone).</p><p>No metabolite has been found to have any effect on gastric acid secretion.</p><p><u>&nbsp;</u></p><p><u>Special populations</u></p><p><em><u>Hepatic impairment</u></em></p><p>The metabolism of omeprazole in patients with liver dysfunction is impaired, resulting in an increased AUC. Omeprazole has not shown any tendency to accumulate with once daily dosing.</p><p><em><u>Renal impairment</u></em></p><p>The pharmacokinetics of omeprazole, including systemic bioavailability and elimination rate, are unchanged in patients with reduced renal function.</p><p><em><u>Elderly</u></em></p><p>The metabolism rate of omeprazole is somewhat reduced in elderly subjects (75-79 years of age).</p><p><em><u>Paediatric population</u></em></p><p>During treatment with the recommended doses to children from the age of 1 year, similar plasma concentrations were obtained as compared to adults. In children younger than 6 months, clearance of omeprazole is low due to low capacity to metabolise omeprazole.</p><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastric ECL-cell hyperplasia and carcinoids, have been observed in life-long studies in rats treated with omeprazole. These changes are the result of sustained hypergastrinaemia secondary to acid inhibition. Similar findings have been made after treatment with H<sub>2</sub>-receptor antagonists, proton pump inhibitors and after partial fundectomy. Thus, these changes are not from a direct effect of any individual active substance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Content:<br />Disodium phosphate dihydrate,<br />Hydroxypropylcellulose,<br />Hypromellose,<br />Lactose anhydrous,<br />Magnesium stearate,<br />Mannitol,<br />Methacrylic acid &ndash; ethyl acrylate copolymer (1:1) dispersion 30 per cent,<br />Cellulose microcrystalline,<br />Macrogol (polyethylene glycol 400),<br />Sodium laurilsulfate,<br />Capsule shell:<br />Iron oxide E172,<br />Titanium dioxide E171,<br />Gelatine,<br />Magnesium stearate,<br />Sodium laurilsulfate,<br />Printing ink (containing shellac, ammonia, potassium hydroxide and black iron oxide E172),<br />Silica colloidal anhydrous,<br />Paraffin liquid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;None Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C.</p><p>Store in the original container to protect from light and moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>White high density polyethylene jar with white polypropylene screw cap containing desiccant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep medicines out of reach and sight of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>